These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3030098)

  • 21. Hypercalcemia associated with increased serum calcitriol levels in three patients with lymphoma.
    Breslau NA; McGuire JL; Zerwekh JE; Frenkel EP; Pak CY
    Ann Intern Med; 1984 Jan; 100(1):1-6. PubMed ID: 6546327
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of estrogen on daylong circulating calcium, phosphorus, 1,25-dihydroxyvitamin D, and parathyroid hormone in postmenopausal women.
    Packer E; Holloway L; Newhall K; Kanwar G; Butterfield G; Marcus R
    J Bone Miner Res; 1990 Aug; 5(8):877-84. PubMed ID: 2173358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of infusion of human parathyroid hormone-related protein-(1-40) in nude mice: histomorphometric and biochemical investigations.
    Rosol TJ; Capen CC; Horst RL
    J Bone Miner Res; 1988 Dec; 3(6):699-706. PubMed ID: 2855193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of tumor hypercalcemia with clodronate.
    Ziegler R; Scharla SH
    Recent Results Cancer Res; 1989; 116():46-53. PubMed ID: 2527400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of cinacalcet on hypercalcemia and bone mineral density in renal transplanted patients with secondary hyperparathyroidism.
    Bergua C; Torregrosa JV; Fuster D; Gutierrez-Dalmau A; Oppenheimer F; Campistol JM
    Transplantation; 2008 Aug; 86(3):413-7. PubMed ID: 18698244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of treatment of malignancy-associated hypercalcemia on serum parathyroid hormone-related protein.
    Budayr AA; Zysset E; Jenzer A; Thiébaud D; Ammann P; Rizzoli R; Jaquet-Müller F; Bonjour JP; Gertz B; Burckhardt P
    J Bone Miner Res; 1994 Apr; 9(4):521-6. PubMed ID: 8030440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of etidronate disodium on the interactions between malignancy and bone.
    Garattini S; Guaitani A; Mantovani A
    Am J Med; 1987 Feb; 82(2A):29-33. PubMed ID: 3103435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary cyclic AMP analyzed as a function of the serum calcium and parathyroid hormone in the idfferential diagnosis of hypercalcemia.
    Shaw JW; Oldham SB; Rosoff L; Bethune JE; Fichman MP
    J Clin Invest; 1977 Jan; 59(1):14-21. PubMed ID: 187621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of etidronate disodium on bone turnover following surgical menopause.
    Smith ML; Fogelman I; Hart DM; Scott E; Bevan J; Leggate I
    Calcif Tissue Int; 1989 Feb; 44(2):74-9. PubMed ID: 2492893
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disodium pamidronate in the preoperative treatment of hypercalcemia in patients with primary hyperparathyroidism.
    Jansson S; Tisell LE; Lindstedt G; Lundberg PA
    Surgery; 1991 Sep; 110(3):480-6. PubMed ID: 1845370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathogenesis of hypercalcemia in nude mice bearing a human renal carcinoma.
    Strewler GJ; Wronski TJ; Halloran BP; Miller SC; Leung SC; Williams RD; Nissenson RA
    Endocrinology; 1986 Jul; 119(1):303-10. PubMed ID: 3013591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ketoconazole decreases the serum ionized calcium and 1,25-dihydroxyvitamin D levels in tuberculosis-associated hypercalcemia.
    Saggese G; Bertelloni S; Baroncelli GI; Di Nero G
    Am J Dis Child; 1993 Mar; 147(3):270-3. PubMed ID: 8438806
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypercalcemia in patients with disseminated coccidioidomycosis.
    Caldwell JW; Arsura EL; Kilgore WB; Reddy CM; Johnson RH
    Am J Med Sci; 2004 Jan; 327(1):15-8. PubMed ID: 14722391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypercalcemia in association with a Leydig cell tumor in the rat: a model for tumor-induced hypercalcemia in man.
    Berger ME; Golub MS; Sowers JR; Brickman AS; Nyby M; Troyer H; Rude RK; Singer FR; Horst R; Deftos LJ
    Life Sci; 1982 May; 30(18):1509-15. PubMed ID: 6281603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bone turnover in rats treated with 1,25-dihydroxyvitamin D3, 25-hydroxyvitamin D3 or 24,25-dihydroxyvitamin D3.
    Mortensen BM; Gautvik KM; Gordeladze JO
    Biosci Rep; 1993 Feb; 13(1):27-39. PubMed ID: 8392394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravenous pamidronic acid in hypercalcemia due to parathyroid carcinoma.
    Vega EM; Mautalen CA
    Medicina (B Aires); 1991; 51(2):106-10. PubMed ID: 1820495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of aminohydroxypropylidene diphosphonate on the bone metabolism of patients with parathyroid adenoma.
    Ishimura E; Miki T; Koyama H; Harada K; Nakatsuka K; Inaba M; Nishizawa Y; Morii H
    Horm Metab Res; 1993 Sep; 25(9):493-7. PubMed ID: 8225204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Etidronate for hypercalcemia of malignancy and osteoporosis.
    Horowitz E; Miller JL; Rose LI
    Am Fam Physician; 1991 Jun; 43(6):2155-9. PubMed ID: 1904188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Humoral hypercalcemia of malignancy: a syndrome in search of a hormone.
    Gottleib S; Rude RK; Sharp CF; Singer FR
    Am J Med; 1982 Nov; 73(5):751-5. PubMed ID: 6291389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Case report: hypercalcemia with inappropriate 1,25-dihydroxyvitamin D in Wegener's granulomatosis.
    Shaker JL; Redlin KC; Warren GV; Findling JW
    Am J Med Sci; 1994 Aug; 308(2):115-8. PubMed ID: 8042652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.